Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

Albert Fournier, Roxana Oprisiu, Jean Michel Achard, Olaf H. Klungel, Hubert G M Leufkens, Anthonius De Boer, W. T. Longstreth, Robert C. Kaplan, Nicholas L. Smith, Bruce M. Psaty

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)2152-2153
Number of pages2
JournalArchives of Internal Medicine
Volume161
Issue number17
DOIs
StatePublished - Sep 24 2001
Externally publishedYes

Fingerprint

Benzothiadiazines
Sodium Chloride Symporter Inhibitors
Cerebral Infarction
Calcium Channel Blockers
Secondary Prevention
Combination Drug Therapy
Diuretics
Antihypertensive Agents
Case-Control Studies
Stroke
Clinical Trials
Hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters). / Fournier, Albert; Oprisiu, Roxana; Michel Achard, Jean; Klungel, Olaf H.; Leufkens, Hubert G M; De Boer, Anthonius; Longstreth, W. T.; Kaplan, Robert C.; Smith, Nicholas L.; Psaty, Bruce M.

In: Archives of Internal Medicine, Vol. 161, No. 17, 24.09.2001, p. 2152-2153.

Research output: Contribution to journalArticle

Fournier, A, Oprisiu, R, Michel Achard, J, Klungel, OH, Leufkens, HGM, De Boer, A, Longstreth, WT, Kaplan, RC, Smith, NL & Psaty, BM 2001, 'Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)', Archives of Internal Medicine, vol. 161, no. 17, pp. 2152-2153. https://doi.org/10.1001/archinte.161.17.2152
Fournier, Albert ; Oprisiu, Roxana ; Michel Achard, Jean ; Klungel, Olaf H. ; Leufkens, Hubert G M ; De Boer, Anthonius ; Longstreth, W. T. ; Kaplan, Robert C. ; Smith, Nicholas L. ; Psaty, Bruce M. / Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters). In: Archives of Internal Medicine. 2001 ; Vol. 161, No. 17. pp. 2152-2153.
@article{aee8e363a0194d4b8c7e4ee1862fd20f,
title = "Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)",
author = "Albert Fournier and Roxana Oprisiu and {Michel Achard}, Jean and Klungel, {Olaf H.} and Leufkens, {Hubert G M} and {De Boer}, Anthonius and Longstreth, {W. T.} and Kaplan, {Robert C.} and Smith, {Nicholas L.} and Psaty, {Bruce M.}",
year = "2001",
month = "9",
day = "24",
doi = "10.1001/archinte.161.17.2152",
language = "English (US)",
volume = "161",
pages = "2152--2153",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "17",

}

TY - JOUR

T1 - Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

AU - Fournier, Albert

AU - Oprisiu, Roxana

AU - Michel Achard, Jean

AU - Klungel, Olaf H.

AU - Leufkens, Hubert G M

AU - De Boer, Anthonius

AU - Longstreth, W. T.

AU - Kaplan, Robert C.

AU - Smith, Nicholas L.

AU - Psaty, Bruce M.

PY - 2001/9/24

Y1 - 2001/9/24

UR - http://www.scopus.com/inward/record.url?scp=0035944363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035944363&partnerID=8YFLogxK

U2 - 10.1001/archinte.161.17.2152

DO - 10.1001/archinte.161.17.2152

M3 - Article

VL - 161

SP - 2152

EP - 2153

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 17

ER -